Emergo Therapeutics

Emergo Therapeutics Focuses on Developing Drugs that Modulate Inflammatory Cytokines and Enhance Immune System Function for Various Potential Indications, Starting with Infectious Diseases. Emergo believes that inflammation caused by mast cells is responsible for some of the most devastating symptoms and outcomes in seemingly unrelated diseases. Mast cells are an essential group of cells in the innate immune system. Despite substantial evidence indicating the therapeutic benefits of targeting mast cells, the vast majority of these conditions remain untreated by mast cell-directed therapies. Emergo’s therapeutic interventions primarily aim to reduce the production of inflammatory cytokines by mast cells.